PL374385A1 - 1-tia-3-azadibenzoazuleny jako inhibitory wytwarzania czynnika martwiczego nowotworu i związki pośrednie do ich wytwarzania - Google Patents

1-tia-3-azadibenzoazuleny jako inhibitory wytwarzania czynnika martwiczego nowotworu i związki pośrednie do ich wytwarzania

Info

Publication number: PL374385A1
Authority: PL; Poland
Prior art keywords: dibenzoazulenes; thia; aza; intermediates; inhibitors
Prior art date: 2002-05-23

Application number

PL03374385A

Other languages

English (en)

Inventor

Mladen Mercep

Milan Mesic

Marina Modric

Dijana Pesic

Davor Kidemet

Original Assignee

Pliva-Istrazivacki Institut D.O.O.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-23

Filing date

2003-05-20

Publication date

2005-10-17

2003-05-20 Application filed by Pliva-Istrazivacki Institut D.O.O. filed Critical Pliva-Istrazivacki Institut D.O.O.

2005-10-17 Publication of PL374385A1 publication Critical patent/PL374385A1/pl

Links

GOCMMZVVJOYRHM-UHFFFAOYSA-N 5-thia-3-azatetracyclo[12.4.0.02,6.08,13]octadeca-1(18),2,6,8,10,12,14,16-octaene Chemical class S1CN=C2C3=C(C4=C(C=C12)C=CC=C4)C=CC=C3 GOCMMZVVJOYRHM-UHFFFAOYSA-N 0.000 title 1
102000018594 Tumour necrosis factor Human genes 0.000 title 1
108050007852 Tumour necrosis factor Proteins 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
239000000543 intermediate Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Neurology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Hematology (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

PL03374385A 2002-05-23 2003-05-20 1-tia-3-azadibenzoazuleny jako inhibitory wytwarzania czynnika martwiczego nowotworu i związki pośrednie do ich wytwarzania PL374385A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HR20020451A HRP20020451A2 (en)	2002-05-23	2002-05-23	1-tia-3-aza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof

Publications (1)

Publication Number	Publication Date
PL374385A1 true PL374385A1 (pl)	2005-10-17

Family

ID=29559972

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL03374385A PL374385A1 (pl)	2002-05-23	2003-05-20	1-tia-3-azadibenzoazuleny jako inhibitory wytwarzania czynnika martwiczego nowotworu i związki pośrednie do ich wytwarzania

Country Status (12)

Country	Link
US (1)	US7262302B2 (pl)
EP (1)	EP1509532A1 (pl)
JP (1)	JP2005529157A (pl)
CN (1)	CN1315847C (pl)
AR (1)	AR039860A1 (pl)
AU (1)	AU2003232370A1 (pl)
CA (1)	CA2486821A1 (pl)
HR (1)	HRP20020451A2 (pl)
IS (1)	IS7566A (pl)
PL (1)	PL374385A1 (pl)
RS (1)	RS100004A (pl)
WO (1)	WO2003099827A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HRP20020304B1 (en) *	2002-04-10	2008-04-30	GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.	1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20030957A2 (en) *	2003-11-21	2005-08-31	Pliva-Istra�iva�ki institut d.o.o.	USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
US20080096830A1 (en) *	2005-01-13	2008-04-24	Mladen Mercep	Anti-Inflammatory Macrolide Conjugates
US8779154B2 (en) *	2006-09-26	2014-07-15	Qinglin Che	Fused ring compounds for inflammation and immune-related uses
TWI443096B (zh)	2012-12-18	2014-07-01	Ind Tech Res Inst	３－（５－（４－（３－氟丙基）哌嗪－１－基）苯並咪唑－２－基）－１－氮雜薁－２－酮之單水合晶型及其製備方法與藥學組成物
AU2018236233A1 (en) *	2017-03-14	2019-09-19	Dana-Farber Cancer Institute, Inc.	Small molecule sensitization of BAX activation for induction of cell death
CN116041360B (zh) *	2021-10-27	2025-07-22	广州华睿光电材料有限公司	有机化合物及包括其的混合物、组合物和有机电子器件

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3711489A (en) *	1971-03-31	1973-01-16	Pfizer	Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
CA967573A (en)	1972-12-22	1975-05-13	Joseph G. Lombardino	Tetracyclic anti-inflammatory agents
US4198421A (en) *	1978-11-30	1980-04-15	E. I. Du Pont De Nemours And Company	Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
HRP20000310A2 (en)	2000-05-17	2002-02-28	Pliva Farmaceutska Ind Dioniko	New dibenzoazulene compounds as tumor necrosis factor inhibitors

2002
- 2002-05-23 HR HR20020451A patent/HRP20020451A2/hr not_active Application Discontinuation
2003
- 2003-05-20 EP EP03755235A patent/EP1509532A1/en not_active Withdrawn
- 2003-05-20 PL PL03374385A patent/PL374385A1/pl not_active Application Discontinuation
- 2003-05-20 CN CNB038161060A patent/CN1315847C/zh not_active Expired - Fee Related
- 2003-05-20 US US10/515,700 patent/US7262302B2/en not_active Expired - Fee Related
- 2003-05-20 JP JP2004507484A patent/JP2005529157A/ja active Pending
- 2003-05-20 RS YU100004A patent/RS100004A/sr unknown
- 2003-05-20 AU AU2003232370A patent/AU2003232370A1/en not_active Abandoned
- 2003-05-20 CA CA002486821A patent/CA2486821A1/en not_active Abandoned
- 2003-05-20 WO PCT/HR2003/000023 patent/WO2003099827A1/en not_active Ceased
- 2003-05-23 AR ARP030101802A patent/AR039860A1/es unknown
2004
- 2004-11-29 IS IS7566A patent/IS7566A/is unknown

Also Published As

Publication number	Publication date
US20060111340A1 (en)	2006-05-25
RS100004A (sr)	2006-10-27
US7262302B2 (en)	2007-08-28
AU2003232370A1 (en)	2003-12-12
EP1509532A1 (en)	2005-03-02
WO2003099827A1 (en)	2003-12-04
JP2005529157A (ja)	2005-09-29
CN1665822A (zh)	2005-09-07
IS7566A (is)	2004-11-29
HK1081949A1 (en)	2006-05-26
AR039860A1 (es)	2005-03-02
CA2486821A1 (en)	2003-12-04
CN1315847C (zh)	2007-05-16
HRP20020451A2 (en)	2003-12-31

Legal Events

Date	Code	Title	Description
2011-02-28	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
GB2432159B (en)	2007-06-27	Intermediates for manufacturing peripherally-selective inhibitors of dopamine-beta-hydroxylase
PL375389A1 (pl)	2005-11-28	Nowe inhibitory kinaz
EP1549316A4 (en)	2008-04-09	HAMMER OF TFGbeta
HUP0500851A3 (en)	2008-02-28	Process for the preparation of rosuvastatin
IL180290A0 (en)	2007-06-03	Process for production of azulene derivatives and intermediates for the synthesis of the same
AU2003217105A1 (en)	2003-09-16	Novel of cytokine inhibitors
AU2002334321A1 (en)	2003-09-29	Method for the production of phytoalexins
PL374279A1 (pl)	2005-10-03	Nitrooksypochodne inhibitorów cyklooksygenazy-2
AU2003206803A1 (en)	2003-09-02	Production of alkenones
HRP20020440A2 (en)	2004-06-30	1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
AU2003299227A1 (en)	2004-07-14	Synthesis of amines and intermediates for the synthesis thereof
PL374385A1 (pl)	2005-10-17	1-tia-3-azadibenzoazuleny jako inhibitory wytwarzania czynnika martwiczego nowotworu i związki pośrednie do ich wytwarzania
PL374504A1 (pl)	2005-10-31	1,3-diazadibenzoazuleny jako inhibitory wytwarzania czynnika martwiczego nowotworu i związki pośrednie do ich wytwarzania
AU2003232371A8 (en)	2003-12-02	1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
IL173736A0 (en)	2006-07-05	Process for the preparation of renzapride and intermediates thereof
AU2002307100A1 (en)	2002-10-21	Use of tumor necrosis factor inhibitors to treat cardiovascular disease
NO20052859D0 (no)	2005-06-13	Fremgangsmate for fremstilling av resperidon og intermediater derav
AU2003219580A1 (en)	2003-10-20	Novel therapeutical use of byakangelicin
AU2003232368A8 (en)	2003-12-12	1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
ZA200604680B (en)	2009-04-29	Process for the preparation of tubulin inhibitors
PL371427A1 (pl)	2005-06-13	Nowe zastosowania podstawionych kwasów aminoalkanofosfonowych
GB2398029B (en)	2005-05-18	Production of disc components
AU2003278323A1 (en)	2005-05-26	Manufacture of hardfaced plates
SI1492797T1 (sl)	2006-08-31	1-oksa-3-aza-dibenzoazuleni kot inhibitorji proizvajanja faktorja tumorske nekroze in intermediati za njihovo pripravo
PL1622926T3 (pl)	2009-12-31	Nowy sposób i produkty pośrednie wytwarzania związków 19-norsteroidów fluorowcowanych w pozycji 17